Best Crypto To Buy Now; Ethereum Price Could Surge As Trump Media Set For $105 Million CRO Buy

來源 Cryptopolitan

The crypto market is heating up as investors hunt for the best crypto to buy now. While Ethereum shows potential for a price surge following Trump Media’s $105 million CRO acquisition, another standout is Remittix (RTX).

Focused on fast, low-cost cross-border payments, Remittix is gaining attention for real-world utility. With its presale momentum and upcoming wallet beta, RTX is positioning itself as a top choice for savvy investors in 2025.

BlackRock Leads Massive ETH Purchase That Sparks Market Optimism

Ethereum is grabbing attention as institutional whales pile in despite recent price dips. BlackRock’s purchase of $323.1 million worth of ETH has sparked optimism, signaling strong confidence in the asset. Even as ETH Price today slipped to $4,420, inflows into Ethereum ETFs reached $28.8 billion, showing institutions view dips as buying opportunities.

Fidelity and Grayscale also added millions, reinforcing Ethereum’s growing mainstream appeal. Analysts note that repeated large purchases highlight long-term faith in ETH’s role in DeFi, staking, and tokenized assets. With broader adoption and rising regulation, Ethereum Price Prediction trends point to potential surges. 

Meanwhile, Bitcoin lags behind but remains steady. This is just a testament to Ethereum’s increasing dominance among institutional investors. For those seeking the best crypto to buy now, Ethereum remains a strong contender.

Cronos Price Surges As Trump Media Confirms $105 Million Buy

Cronos is surging as Trump Media & Technology Group makes a bold move to integrate CRO into its platforms. The partnership with Crypto.com and Yorkville Acquisition Corp. includes a $105 million initial buy, boosting CRO Price today by 26%.

Trump Media plans to back a $6.42 billion CRO treasury, creating the world’s largest digital asset treasury strategy. The collaboration adds CRO rewards to Truth Social and Truth+, while securing 6.3 billion tokens, roughly 19% of the CRO market cap. Analysts highlight this as a game-changing move for CRO Price Prediction and overall adoption.

With cash injections, warrants, and equity lines totaling over $5 billion, Cronos gains unique institutional support. The Cronus Price rally contrasts the broader crypto market struggling under downward pressure, marking CRO as one of the best altcoins to watch.

Strategic Partnerships Could Accelerate Remittix Adoption

Remittix (RTX) is emerging as the best crypto to buy now, drawing attention from investors tired of meme coins and AI tokens that have lost billions. The platform focuses on real-world usability, enabling fast, low-cost cross-border payments.

Over 622 million tokens were sold at $0.0987 each, raising $21.6 million. This is proof that investors are backing practical solutions. Analysts note that Remittix could replicate XRP’s early adoption success without the regulatory headaches associated with it.

The Remittix Wallet will enter beta testing on September 15th, 2025, giving select community members early access. The team currently has several strategic partnerships with banks and payment platforms in the works. These partnerships are set to boost adoption and liquidity. The $20M presale milestone has already unlocked the first centralized exchange listing with BitMart. This upcoming listing will ensure instant access for new investors.

  • Seamless crypto-to-fiat payments within 24 hours
  • Over 50 crypto pairs and 30 fiat currencies supported
  • Privacy-focused transactions appearing as standard bank transfers
  • Stake $RTX and earn rewards while using the platform

Remittix continues expanding, positioning itself as a leading PayFi solution in 2025.

Discover the future of PayFi with Remittix by checking out their project here:

Website: https://remittix.io/ 

Socials: https://linktr.ee/remittix 

$250K Giveaway: https://gleam.io/competitions/nz84L-250000-remittix-giveaway 

免責聲明:僅供參考。 過去的表現並不預示未來的結果。
placeholder
輝達財報無驚喜?大摩稱指引或保守,高盛指2025下半年漲幅有限高盛指出,若中國市場業務方面沒有實質進展,股價可能因缺乏催化劑而承壓。
作者  Tony Chou
8 月 26 日 週二
高盛指出,若中國市場業務方面沒有實質進展,股價可能因缺乏催化劑而承壓。
placeholder
益登(3048)連兩日亮燈漲停!主力狂鎖萬張 下個噴出點就在這時機?​投資慧眼Insights-益登宣佈開賣輝達機器人新套件,引爆市場行情,連續兩天亮燈漲停!
作者  投資指南針
昨日 04: 05
​投資慧眼Insights-益登宣佈開賣輝達機器人新套件,引爆市場行情,連續兩天亮燈漲停!
placeholder
揭秘輝達財報超預期,股價反而下跌的四大原因:股票投資非簡單數字遊戲美國AI晶片龍頭輝達(Nvidia)於台灣時間28日凌晨公布最新季度財報,2026財年第二季營收達467億美元,高於市場預期。然而財報公布後,輝達盤後股價卻一度重挫5%,之後稍有回彈,收盤時下跌0.09%,收在181.60美元。對於第三季的財測,輝達預估營收約540億美元,上下浮動2%,略高於市場預估的534.6億美元。
作者  財富進化論
10 小時前
美國AI晶片龍頭輝達(Nvidia)於台灣時間28日凌晨公布最新季度財報,2026財年第二季營收達467億美元,高於市場預期。然而財報公布後,輝達盤後股價卻一度重挫5%,之後稍有回彈,收盤時下跌0.09%,收在181.60美元。對於第三季的財測,輝達預估營收約540億美元,上下浮動2%,略高於市場預估的534.6億美元。
placeholder
【抽1張現賺17.8萬】大研生醫申購開跑!報酬率113%引爆投資人瘋搶​投資慧眼Insights-保健品大廠大研生醫(7780)申購今(28)日開放,承銷價定為158元,以昨日收盤價計算,抽中一張有望現賺17萬!
作者  投資指南針
8 小時前
​投資慧眼Insights-保健品大廠大研生醫(7780)申購今(28)日開放,承銷價定為158元,以昨日收盤價計算,抽中一張有望現賺17萬!
placeholder
外資狂買、股價衝高14元:群創的轉型盛宴,最後誰來買單?群創股價近日表現強勢,28日盤中一度衝高至14.15元,漲幅最高逼近6%,外資連續買超推升氣勢如虹。
作者  投資-槓把子
4 小時前
群創股價近日表現強勢,28日盤中一度衝高至14.15元,漲幅最高逼近6%,外資連續買超推升氣勢如虹。
goTop
quote